Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 European lead factory opens for business.

Literature DB >> 23449292

European lead factory opens for business.

Asher Mullard.

Abstract

Mesh：

Year: 2013 PMID： 23449292 DOI： 10.1038/nrd3956

Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694

Keyword Cloud
Cited

× No keyword cloud information.

19 in total

1. Opening the lead generation toolbox.

Authors: Peter B Simpson; Melvin Reichman
Journal: Nat Rev Drug Discov Date: 2014-01 Impact factor: 84.694

Review 2. Malaria medicines: a glass half full?

Authors: Timothy N C Wells; Rob Hooft van Huijsduijnen; Wesley C Van Voorhis
Journal: Nat Rev Drug Discov Date: 2015-05-22 Impact factor: 84.694

3. MCR synthesis of a tetracyclic tetrazole scaffold.

Authors: Pravin Patil; Kareem Khoury; Eberhardt Herdtweck; Alexander Dömling
Journal: Bioorg Med Chem Date: 2014-12-20 Impact factor: 3.641

4. Impact of a five-dimensional framework on R&D productivity at AstraZeneca.

Authors: Paul Morgan; Dean G Brown; Simon Lennard; Mark J Anderton; J Carl Barrett; Ulf Eriksson; Mark Fidock; Bengt Hamrén; Anthony Johnson; Ruth E March; James Matcham; Jerome Mettetal; David J Nicholls; Stefan Platz; Steve Rees; Michael A Snowden; Menelas N Pangalos
Journal: Nat Rev Drug Discov Date: 2018-01-19 Impact factor: 84.694

5. The innovative medicines initiative: a public private partnership model to foster drug discovery.

Authors: Elisabetta Vaudano
Journal: Comput Struct Biotechnol J Date: 2013-11-27 Impact factor: 7.271

Review 6. Opening the door to innovation.

Authors: Janine Schuurman; Yvo F Graus; Aran F Labrijn; Sigrid Ruuls; Paul W H I Parren
Journal: MAbs Date: 2014-04-24 Impact factor: 5.857

European lead factory opens for business.

1. Opening the lead generation toolbox.

Review 2. Malaria medicines: a glass half full?

3. MCR synthesis of a tetracyclic tetrazole scaffold.

4. Impact of a five-dimensional framework on R&D productivity at AstraZeneca.

5. The innovative medicines initiative: a public private partnership model to foster drug discovery.

Review 6. Opening the door to innovation.

7. A universal isocyanide for diverse heterocycle syntheses.

8. ChemProt-3.0: a global chemical biology diseases mapping.

9. Ammonia-Promoted One-Pot Tetrazolopiperidinone Synthesis by Ugi Reaction.

10. Sulfur-Switch Ugi Reaction for Macrocyclic Disulfide-Bridged Peptidomimetics.